Lagos, Nigeria – June 2-4, 2026 — WHX Lagos 2026, a leading summit for laboratory medicine and healthcare diagnostics in West Africa, grandly concludes at Landmark Centre, Lagos, Nigeria after a three-day elite industry gathering from June 2 to June 4. As a Platinum Sponsor of the event, Snibe showcased its integrated overall laboratory diagnostic solutions, bringing optimized, cost-effective lab technology tailored for West African medical institutions and clinical laboratories.
Gathering global diagnostic experts, laboratory directors and healthcare industry practitioners across Nigeria and West Africa, WHX Lagos 2026 focuses on local lab upgrading, clinical diagnostic efficiency improvement and sustainable healthcare development of African medical systems. Centering on regional laboratory pain points including compact lab space, diversified testing demands and streamlined workflow management, Snibe launched targeted intelligent diagnostic exhibits during the exhibition.
Highlighted at Booth #H6.B10, the MAGLUMI X3 fully automated chemiluminescence immunoassay analyzer became the core spotlight of the booth. Equipped with more than 260 test parameters, the instrument delivers compact design and stable operational performance, full-process lab automation, and efficient sample detection capacity, perfectly matching routine clinical testing requirements of medium- and small-scale local laboratories. Besides the that, Snibe also showcased the MAGLUMI M800 fully-auto chemiluminescence immunoassay analyzer as a complementary solution. Featuring stable flash chemiluminescence technology, MAGLUMI M800 covers abundant immunoassay test menus, ideal for regional labs with targeted immunodiagnosis demands. Meanwhile, Snibe's one-stop overall lab diagnostic portfolio was displayed on site, covering matched reagents and supporting after-sales technical services, to help local medical labs cut operational costs and boost overall diagnostic efficiency.
During the three-day exhibition, Snibe's professional technical and sales team conducted on-site product demonstrations, in-depth academic exchanges, and customized solution consultations with visiting hospital representatives and lab managers. Attendees highly recognized the compact design, reliable test accuracy, and localized service layout of Snibe diagnostic products, reaching multiple preliminary business cooperation intentions.
With an unwavering commitment over 30 years, Snibe remains at the forefront of in vitro diagnostic solutions, propelling the medical industry forward through relentless scientific and technological innovation. Pledging to stay customer-centric and market-oriented, Snibe is dedicated to creating value for human life and health through continual product and technological advancement. Thank you for your participation, and we eagerly anticipate reconnecting with you next time!
Return